Optimized cyclosporine starting dose may reduce risk of acute GvHD after allogeneic hematopoietic cell transplantation: a single-center cohort study

Cyclosporine A (CsA) is commonly used for Graft versus Host Disease (GvHD) prophylaxis at a recommended starting dose of 3 mg/kg/d: Evidence for the effect of different CsA starting doses on GvHD risk is limited. We therefore estimated the association of 5 mg/kg/d (CsA5) and 3 mg/kg/d (CsA3) CsA sta...

Descripción completa

Detalles Bibliográficos
Autores principales: Héritier, Jérémie, Medinger, Michael, Heim, Dominik, Baldomero, Helen, Arranto, Christian, Halter, Jörg P., Passweg, Jakob R., Kleber, Martina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8993684/
https://www.ncbi.nlm.nih.gov/pubmed/35132203
http://dx.doi.org/10.1038/s41409-022-01598-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8993684/
https://www.ncbi.nlm.nih.gov/pubmed/35132203
http://dx.doi.org/10.1038/s41409-022-01598-6

Ejemplares similares